Capital & Strategic Transactions
Financial governance, fundraising oversight, and exit preparation
Preparing a Biopharma Company for Exit
Exit readiness in biopharma is not a checklist you complete in the months before a transaction. It is an operating posture that takes years to build — and a board discipline that is almost always started too late.
Evaluating Licensing Deals from the Board's Perspective
When management brings a licensing opportunity to the board, the governance questions matter as much as the financial ones. A framework for directors who want to engage substantively.
Managing Runway Pressure Without Panic
When the company has 12 to 18 months of cash remaining, the board's behavior determines whether the outcome is a disciplined raise or a desperate one. A governance framework for capital pressure.
Board Governance During Fundraising Rounds
Fundraising transforms board dynamics. Directors who understand the governance implications navigate it effectively. Those who don't create risk for the company and for themselves.